Literature DB >> 15850856

Breast cancer prevention in community clinics: will low-income Latina patients participate in clinical trials?

Jeanne Mandelblatt1, Elizabeth Kaufman, Vanessa B Sheppard, Jyl Pomeroy, John Kavanaugh, Janet Canar, Laura Pallandre, Jennifer Cullen, Elmer Huerta.   

Abstract

BACKGROUND: Latinas have low rates of participation in breast cancer prevention trials. We evaluated the feasibility and effectiveness of a randomized trial of brief counseling and print materials compared to print materials alone to increase intent to participate in a breast cancer prevention trial.
METHODS: We enrolled 450 women Spanish-speaking women from three urban community primary care clinics. The outcome was intent, defined as might, probably, or definitely would enroll in the trial. We also examined results using a more stringent definition restricted to probably and definitely intend to participate.
RESULTS: The trial was feasible within these busy clinics, and 96% of women agreed to participate. The level of breast cancer knowledge was fairly high (66% correct answers), but understanding about clinical trials was lower (40.5% correct answers). Using the less stringent criteria for intent, 72% of women stated that they intended to enroll in the STAR trial if eligible, but rates of intent decreased to 52% with framing that included medication side effects and 45% if uterine cancer was mentioned (P < 0.01 for trend). Using the more stringent definition, slightly fewer than half of the women indicated an interest in participating, with the same trend towards decreasing intent with increasing presentation of side effects. The intervention was only effective using the less stringent definition and if no side effects were mentioned (77% intent vs. 67% in the intervention and control groups, respectively, P = 0.03). Intention was independently associated with greater worry about breast cancer and younger age, but not acculturation or knowledge.
CONCLUSIONS: Latina women are interested in participating in clinical trials to prevent breast cancer, although interest declines with increasing discussion of side effects. Unfortunately, brief education only increased rates of intention using the least stringent definition and when no side effects were presented in framing the question. Future work should focus on qualitative research to understand the theoretical foundations of preventive health behaviors in this population.

Entities:  

Mesh:

Year:  2005        PMID: 15850856     DOI: 10.1016/j.ypmed.2004.09.004

Source DB:  PubMed          Journal:  Prev Med        ISSN: 0091-7435            Impact factor:   4.018


  18 in total

Review 1.  Reasons for and against participation in studies of medicinal therapies for women with breast cancer: a debate.

Authors:  Gero Luschin; Marion Habersack; Irmina-Anna Gerlich
Journal:  BMC Med Res Methodol       Date:  2012-03-11       Impact factor: 4.615

2.  Assessing the awareness of and willingness to participate in cancer clinical trials among immigrant Latinos.

Authors:  Sherrie Flynt Wallington; Gheorghe Luta; Anne-Michelle Noone; Larisa Caicedo; Maria Lopez-Class; Vanessa Sheppard; Cherie Spencer; Jeanne Mandelblatt
Journal:  J Community Health       Date:  2012-04

3.  Motivators and barriers to Latinas' participation in clinical trials: the role of contextual factors.

Authors:  Laricca London; Alejandra Hurtado-de-Mendoza; Minna Song; Ankita Nagirimadugu; Gheorghe Luta; Vanessa B Sheppard
Journal:  Contemp Clin Trials       Date:  2014-11-26       Impact factor: 2.226

4.  Evaluation of Breast Cancer Knowledge and Awareness Among Hospital Staff in a Women Heath Hospital in Turkey.

Authors:  Gökay Terzioğlu; Emre Özgü; Murat Özgür Kılıç; Yunus Yıldız; Tayfun Güngör
Journal:  J Cancer Educ       Date:  2017-03       Impact factor: 2.037

Review 5.  Recommendations for enhancing clinical trials education: a review of the literature.

Authors:  Karen A Stepan; Amy P Gonzalez; Vivian S Dorsey; Debra K Frye; Nita D Pyle; Regina F Smith; Terry A Throckmorton; Louise A Villejo; Scott B Cantor
Journal:  J Cancer Educ       Date:  2011-03       Impact factor: 2.037

Review 6.  Strategies for increasing recruitment to randomised controlled trials: systematic review.

Authors:  Patrina H Y Caldwell; Sana Hamilton; Alvin Tan; Jonathan C Craig
Journal:  PLoS Med       Date:  2010-11-09       Impact factor: 11.069

7.  Long-term Diet and Biomarker Changes after a Short-term Intervention among Hispanic Breast Cancer Survivors: The ¡Cocinar Para Su Salud! Randomized Controlled Trial.

Authors:  Heather Greenlee; Ann Ogden Gaffney; A Corina Aycinena; Pam Koch; Isobel Contento; Wahida Karmally; John M Richardson; Zaixing Shi; Emerson Lim; Wei-Yann Tsai; Regina M Santella; William S Blaner; Robin D Clugston; Serge Cremers; Susan Pollak; Iryna Sirosh; Katherine D Crew; Matthew Maurer; Kevin Kalinsky; Dawn L Hershman
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2016-07-26       Impact factor: 4.254

8.  Perceived risk of breast cancer among Latinas attending community clinics: risk comprehension and relationship with mammography adherence.

Authors:  Kristi D Graves; Elmer Huerta; Jennifer Cullen; Elizabeth Kaufman; Vanessa Sheppard; George Luta; Claudine Isaacs; Marc D Schwartz; Jeanne Mandelblatt
Journal:  Cancer Causes Control       Date:  2008-08-15       Impact factor: 2.506

9.  Patients' willingness to participate in a breast cancer biobank at screening mammogram.

Authors:  Christoph I Lee; Lawrence W Bassett; Mei Leng; Sally L Maliski; Bryan B Pezeshki; Colin J Wells; Carol M Mangione; Arash Naeim
Journal:  Breast Cancer Res Treat       Date:  2012-11-06       Impact factor: 4.872

10.  Engaging members of African American and Latino communities in preventive HIV vaccine trials.

Authors:  Magdalena E Sobieszczyk; Guozhen Xu; Krista Goodman; Debbie Lucy; Beryl A Koblin
Journal:  J Acquir Immune Defic Syndr       Date:  2009-06-01       Impact factor: 3.731

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.